Currently, pegylated interferon alfa (PEG-IFN-a), entecavir (ETV), and tenofovir disoproxil fumarate (TDF) are the first-line agents in the treatment of hepatitis B disease. These are the main treatment drugs approved globally for this disease, although ongoing trials are investigating new types of medications, such as tenofovir disoproxil in combination with emtricitabine. Encapsidation inhibitors, entry inhibitors, TLR7 agonists, and therapeutic vaccines are all in development...consult good physician they will help you
Answered2015-10-15 09:36:29
Let others know if this answer was helpful